Digestive System

The purpose of this study is to evaluate the safety of different doses of risankizumab and determine how well it works in subjects with moderate to severe Crohn’s disease.

Primary disease category: 
Secondary disease category(ies): 

The purpose of this study is to evaluate the safety of different doses of risankizumab and determine how well it works in subjects with moderate to severe Crohn disease.

Primary disease category: 
Secondary disease category(ies): 
Subscribe to RSS - Digestive System